Low dose radiotherapy for COVID-19 pneumopathy: Biological rationale and literature review
This article explains biological rationale of low-dose radiotherapy, and reports already published or ongoing studies on low-dose radiotherapy for SARS-CoV-2 pneumonia.PMID:33903009 | DOI:10.1016/j.canrad.2021.03.005
Source: Cancer Radiotherapie - Category: Cancer & Oncology Authors: C Miran É Bonnet B Allignet S Clippe M El Hedi Zouai M Bosset B Fleury J-B Guy Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Coronavirus | COVID-19 | Pandemics | Pneumonia | Respiratory Medicine | SARS | Study